Towards the world's first malaria vaccine
25 April 2017 – A WHO-coordinated programme will pilot world’s first malaria vaccine in Ghana, Kenya, and Malawi in 2018. The injectable vaccine was developed to protect young children from the most deadly form of malaria. Global efforts reduced malaria deaths by 62% between 2000 and 2015, yet approximately 429 000 people died of the disease in 2015 – the majority of them young children in Africa.
25 April 2017 – Thanks to a highly effective National Immunization Programme, most Brazilian parents can feel confident that their children will get the lifesaving vaccines they need – when they need them. Routine vaccination coverage in Brazil averages above 95% for most vaccines on the child immunization schedule every year – exceeding WHO’s recommendations. Yet some people remain hard to reach.
21 April 2017 – New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death.
21 April 2017 – Approximately 52 million pregnant women living in sub-Saharan Africa are at risk of exposure to malaria each year. A key preventive therapy – known as intermittent preventive treatment in pregnancy (IPTp) – has been added to the antenatal care package in response. An estimated 69% of pregnant women are not receiving the full cycle of IPTp however, a gap which must be urgently closed.